CC2D1A
protein-codingcoiled-coil and C2 domain containing 1A, the group of C2 domain containing
Gene summary
This gene encodes a transcriptional repressor that binds to a conserved 14-bp 5'-repressor element and regulates expression of the 5-hydroxytryptamine (serotonin) receptor 1A gene in neuronal cells. The DNA binding and transcriptional repressor activities of the protein are inhibited by calcium. A mutation in this gene results in a nonsyndromic form of cognitive disability (MRT3). [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019502
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012037
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: ClinGen
*CC2D1A* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2005 (Basel-Vanagaite et al., PMID: 16033914). At least 5 unique variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and segregation data. This gene-disease relationship is also supported by experimental evidence, including mouse models and expression studies. In summary, there is definitive evidence supporting the relationship between *CC2D1A* and autosomal recessive complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on January 8, 2020 (SOP version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0012037
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0012037
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CC2D1A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017721.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 176 | 3 | 184 | ||
| missense | 1 | 225 | 66 | 2 | 294 | |
| nonsense | 7 | 6 | 13 | |||
| start loss | 0 | |||||
| frameshift | 15 | 12 | 3 | 30 | ||
| splice donor/acceptor (+/-2bp) | 5 | 25 | 5 | 2 | 37 | |
| Total | 27 | 44 | 238 | 244 | 5 | 558 |
Highest pathogenic variant AF is 0.00006478371
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060191.3 | 29 | MANE Select | |
| Ensembl | ENSP00000313601.6 | 29 | MANE Select | |
| RefSeq | NP_001398067.1 | 29 | Standard | |
| Ensembl | ENSP00000465376.1 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
- EGFR1
Biological Process
- negative regulation of transcription by RNA polymerase II
- positive regulation of I-kappaB kinase/NF-kappaB signaling
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- protein binding
- cadherin binding
Cellular Component
- fibrillar center
- nucleus
- microtubule organizing center
- cytosol
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000318003
- Coding exons
- 29
- Length
- 24679
- Individuals with no LoFs
- 124739
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 66
- Defined
- 124805
- p
- 0.000264
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.941 | 541 | 606 | 0.892 | 0.0000402 | 6060 |
| Missense (PolyPhen) | 172 | 199.42 | 0.86249 | 1987 | ||
| Synonymous | 0.212 | 247 | 251 | 0.983 | 0.0000170 | 1983 |
| Loss of Function | 4.99 | 15 | 55.0 | 0.273 | 0.00000286 | 615 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.0019 | 0.0017 | notable |
| East Asian | 0.00045 | 0.00045 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00020 | 0.00019 | rare |
| South Asian | 0.00037 | 0.00036 | rare |
| Other | 0.00051 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor that binds specifically to the DRE (dual repressor element) and represses HTR1A gene transcription in neuronal cells. The combination of calcium and ATP specifically inactivates the binding with FRE. May play a role in the altered regulation of HTR1A associated with anxiety and major depression. Mediates HDAC-independent repression of HTR1A promoter in neuronal cell. Performs essential function in controlling functional maturation of synapses (By similarity). Plays distinct roles depending on its localization. When cytoplasmic, acts as a scaffold protein in the PI3K/PDK1/AKT pathway. Repressor of HTR1A when nuclear. In the centrosome, regulates spindle pole localization of the cohesin subunit SCC1/RAD21, thereby mediating centriole cohesion during mitosis. {ECO:0000250, ECO:0000269|PubMed:20171170}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 3 (MRT3) [MIM:608443]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs. {ECO:0000269|PubMed:16033914}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- LoFtool
- 0.719
- RVIS EVS
- 1.45
- RVIS percentile EVS
- 95.16
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.972
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |